Using electrical stimulation to treat ADHD in children and adolescents
Transcranial Electrical Stimulation Modalities for the Treatment of Clinical Symptoms and Cognitive Deficits in Attention-deficit Hyperactivity Disorder Disorder
This study is testing whether a new type of brain stimulation can help children and teenagers with ADHD manage their symptoms better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 7 Years to 18 Years |
| Sex | All |
| Sponsor | The National Brain Mapping Laboratory (NBML) Academic / other |
| Locations | 1 site (Tehran) |
| Trial ID | NCT06974136 on ClinicalTrials.gov |
What this trial studies
This project investigates the effectiveness of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), as non-invasive treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. ADHD is a neurodevelopmental disorder that affects attention, hyperactivity, and impulsivity, often requiring management through conventional therapies that may have limitations. The study aims to evaluate the therapeutic potential of these neuromodulation techniques to provide an alternative treatment option for affected individuals.
Who should consider this trial
Good fit: Ideal candidates for this study are children and adolescents aged 7-18 diagnosed with ADHD.
Not a fit: Patients with comorbid neurodevelopmental or neurological disorders, or those with a history of neurosurgery, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could offer a novel, non-invasive treatment option for managing ADHD symptoms in children and adolescents.
How similar studies have performed: While the use of tES modalities is a relatively novel approach, preliminary studies have shown promise in similar applications for various neurodevelopmental disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist * being 7-18 years old * providing written informed consent signed by parents Exclusion Criteria: * comorbidity with other neurodevelopmental disorders * Comorbidity with other neurological disorders * previous history of neurosurgery * Presence of any ferromagnetic metal in the head * implanted medical devices in the head or neck region * history of non-controlled epilepsy with seizures in the last year
Where this trial is running
Tehran
- Institute for Research in Fundamental Sciences — Tehran, Iran (Recruiting)
Study contacts
- Study coordinator: Mohammad Ali Salehinejad Haghighi
- Email: salehinejadmohammadali@gmail.com
- Phone: 017642062686
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.